Busy day at Google today: the company rolled out version 2.0 of its Gemini AI assistant (previously announced in December) ...

For a limited time, Amazon is offering up to 40% off Shark's cutting-edge vacuums, mops, air purifiers and even a top-rated ...

U.S. President Donald Trump has repeatedly mentioned pharmaceuticals as another industry that could be targeted by tariffs, ...

Keith Siegel became the first American hostage freed on Saturday as part of an Israel-Hamas ceasefire agreement the U.S. helped broker that aims to ends the war in the Gaza Strip. With his release ...

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today. From reproductive rights to climate change to Big Tech, The ...

Yechi Yehud, father of Arbel who was freed on Thursday from captivity after 482 days, on Friday evening delivered a public statement from Sheba Hospital. "Arbel has come back to us in reasonable ...

BETTENDORF, Iowa (KWQC) - With the cold weather outside, it is time to warm up with some chili, all for a good cause. Lcola organization, Hand in Hand, is hosting its 16th annual Chili Cook-Off on ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

It also converts easily into a handheld unit for more maneuverability. The LED touchscreen allows you to configure settings and see details at a glance, like battery life. Meanwhile, the battery ...

Journavx received FDA approval, the agency announced on Thursday, Jan. 30. The drug developed by Boston-based Vertex Pharmaceuticals blocks sodium channels in the peripheral nervous system, preventing ...

In late 2024, Microsoft Gaming’s Phil Spencer confirmed that the company has plans to produce an Xbox handheld in the coming years. While there are plenty of reasons to get excited about the prospect ...

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries. It’s the first new pharmaceutical approach to ...